New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2014
10:25 EDTSGYP, SGYPSummer Street's chief scientific officer holds analyst/industry conference call
Chief Scientific Officer Classen discusses Synergy Pharmaceuticals' (SGYP) Plecanatide for Irritable Bowel Disease with constipation on an Analyst/Industry conference call to be held on April 17 at 11 am.
News For SGYP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 18, 2014
06:02 EDTSGYPSynergy Pharmaceuticals reaches halfway mark for Phase 3 plecanatide trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use